ESTABLISHMENT AND CHARACTERIZATION OF 2 CELL-LINES DERIVED FROM HUMAN TRANSITIONAL-CELL CARCINOMA

被引:0
作者
CHANG, JW
SUI, ZF
MA, TX
MA, K
ZHANG, X
WANG, JJ
DONG, KQ
YAO, QX
机构
[1] CHINESE ACAD SCI,KUNMING ANIM INST,KUNMING,PEOPLES R CHINA
[2] TIANJIN MED UNIV,AFFILIATED HOSP 2,DEPT UROL SURG,TIANJIN,PEOPLES R CHINA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two continuous cell lines derived from the neoplastic urothelium had been maintained in culture for more than two years. The first cell hue derived from the urothelium of a fusion papillocarcinoma on the left lateral wall of the bladder was designated as TBC-1 and grown in vitro for more than 150 generations. The second cell line derived from the urothelium of a papillocarcinoma in the left renal pelvis was designated as TPC-1 and grown in vitro for more than 100 generations. Characterization studies made on both cell lines showed that the cells had a rapid doubling time, exhibited multilayering and produced tumors in sc of BALB / c. Tumor nodules that produced sc of BALB / c kept similar cellular and pathological features to those of the primary biopsy specimens under light and electron microscopes. TPC-1 cell line exhibited a three-dimensional structure of transitional epithelium on the nylon-mesh disk which was coated with a layer of rat tail collagen. Both TBC-1 and TPC-1 cell lines formed colonies in soft agar. Their forming rates were 35% and 28%, respectively. The chromosome number of TBC-1 cells ranged from 17 to 84, with a modal number of 54; whereas that of TPC-1 cells ranged from 28 to 139, with a modal number of 49, The TBC-1 cells showed mutant p53 and ras p21 protein expression and expressed weakly ABH blood group isoantigens. Analysis of lactic dehydrogenase (LDH) isozymes showed the highest levels of LDH isozyme 4 sonicated cell lysates of TBC-1 and TPC-1 respectively.
引用
收藏
页码:522 / 527
页数:6
相关论文
共 11 条
[1]   CURRENT STATUS OF CHEMOTHERAPY SENSITIVITY TESTING FOR UROLOGICAL MALIGNANCIES [J].
CHIN, JL ;
SLOCUM, HK ;
BULBUL, MA ;
RUSTUM, YM .
JOURNAL OF UROLOGY, 1986, 136 (03) :555-560
[2]  
Fradet Y, 1993, Semin Urol, V11, P145
[3]  
HEPBURN PJ, 1983, PATHOLOGY BLADDER CA, P213
[4]   ESTABLISHMENT AND CHARACTERIZATION OF 3 NEW HUMAN OVARIAN-CARCINOMA CELL-LINES AND INITIAL EVALUATION OF THEIR POTENTIAL IN EXPERIMENTAL CHEMOTHERAPY STUDIES [J].
HILL, BT ;
WHELAN, RDH ;
GIBBY, EM ;
SHEER, D ;
HOSKING, LK ;
SHELLARD, SA ;
RUPNIAK, HT .
INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (02) :219-225
[5]  
Jones P A, 1993, Semin Urol, V11, P177
[6]  
MASTERS JRW, 1986, CANCER RES, V46, P3630
[7]   CELL SURFACE-A, B OR O(H) BLOOD-GROUP ANTIGENS AS AN INDICATOR OF MALIGNANT POTENTIAL IN STAGE-A BLADDER-CARCINOMA [J].
NEWMAN, AJ ;
CARLTON, CE ;
JOHNSON, S .
JOURNAL OF UROLOGY, 1980, 124 (01) :27-29
[8]  
SIDRANSKY D, 1992, UROL CLIN N AM, V19, P629
[9]  
TOMOYUKI S, 1993, SEMIN UROL, V11, P113
[10]   CELLULAR HETEROGENEITY AND DRUG-RESISTANCE IN 2 OVARIAN ADENOCARCINOMA CELL-LINES DERIVED FROM A SINGLE PATIENT [J].
WOLF, CR ;
HAYWARD, IP ;
LAWRIE, SS ;
BUCKTON, K ;
MCINTYRE, MA ;
ADAMS, DJ ;
LEWIS, AD ;
SCOTT, ARR ;
SMYTH, JF .
INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (06) :695-702